Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by GH Research PLC

GH Research Announces Pricing of $150 Million Public Offering
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Announces Proposed Public Offering
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Announces Primary Endpoint Met in Phase 2b Trial with GH001 in TRD Demonstrating -15.5 Point Placebo-adjusted MADRS Reduction
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research to Provide Update on Phase 2b Trial with GH001 in TRD
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Reports Third Quarter Financial Results and Provides Business Updates
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Reports Full Year 2022 Financial Results and Provides Business Updates
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Provides Business Updates and Highlights Key Upcoming Milestones
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
GH Research Reports Third Quarter 2022 Financial Results and Provides Business Updates
From GH Research PLC
Via GlobeNewswire
Tickers GHRS
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.